Therefore, erastin and sorafenib treatment can ameliorate liver fibrosis by downregulating ZFP36, activating ferritinophagy, and ferroptosis in HSCs (Zhang et al., 2020a). Here, ZFP36 is linked to Hepatic fibrosis.